Study of MT-6402 in Subjects With Advanced Solid Cancer That Expresses PD-L1

NCT04795713 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

64

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated by Sponsor

Conditions

Advanced Solid Tumor
Non-small Cell Lung Cancer
Squamous Cell Carcinoma of Head and Neck

Interventions

DRUG: MT-6402

Sponsor

Molecular Templates, Inc.